Clinical trial
Atorvastatin and Clopidogrel HIgh DOse in Stable Patients With Residual High Platelet Activity
NCT01335048 is registered in ClinicalTrials.gov with Ospedale Misericordia e Dolce as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Atorvastatin and Clopidogrel HIgh DOse in Stable Patients With Residual High Platelet Activity
- Lead sponsor
- Ospedale Misericordia e Dolce
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- January 31, 2012
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
stable angina